JENNIFER LOVELESS to Immunocompromised Host
This is a "connection" page, showing publications JENNIFER LOVELESS has written about Immunocompromised Host.
Connection Strength
0.051
-
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness. Clin Infect Dis. 2026 Jan 16; 81(Supplement_3):i1-i5.
Score: 0.051